Process for the Production of Peglated Staphylokinase (SAK)
Implementing Organization
Council of Scientific & Industrial Research (CSIR)
Project Overview
This invention relates to the production process of peglated staphylokinase (SAK) having extended plasma half-life and high stability. It is used as a clot bluster drug. PEGylated SAK derivatives have better potential for the efficient and cost-effective treatment of cardio-vascular diseases. As a clot bluster drug, SAK is considerably more fibrin-specific than streptokinase.
Council of Scientific & Industrial Research (CSIR)
Acces sibility Controls